Global Oral Rotavirus Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oral Rotavirus Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Oral Rotavirus Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Rotavirus Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Vaccination Station are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Rotavirus Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Rotavirus Vaccine key manufacturers include GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group and Sinovac Biotech, etc. GSK, Sanofi-Pasteur, Merck are top 3 players and held % sales share in total in 2022.
Oral Rotavirus Vaccine can be divided into Rotarix, RotaTeq, Rotavac and Rotavin-M1, etc. Rotarix is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Rotavirus Vaccine is widely used in various fields, such as Hospital, Vaccination Station and Other,, etc. Hospital provides greatest supports to the Oral Rotavirus Vaccine industry development. In 2022, global % sales of Oral Rotavirus Vaccine went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Rotavirus Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Hospital
Vaccination Station
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Rotavirus Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Rotavirus Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Rotavirus Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Rotavirus Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Rotavirus Vaccine introduction, etc. Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oral Rotavirus Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Oral Rotavirus Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Rotavirus Vaccine key manufacturers include GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group and Sinovac Biotech, etc. GSK, Sanofi-Pasteur, Merck are top 3 players and held % sales share in total in 2022.
Oral Rotavirus Vaccine can be divided into Rotarix, RotaTeq, Rotavac and Rotavin-M1, etc. Rotarix is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Rotavirus Vaccine is widely used in various fields, such as Hospital, Vaccination Station and Other,, etc. Hospital provides greatest supports to the Oral Rotavirus Vaccine industry development. In 2022, global % sales of Oral Rotavirus Vaccine went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Rotavirus Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Segment by Application
Hospital
Vaccination Station
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Rotavirus Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Rotavirus Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Rotavirus Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Rotavirus Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Rotavirus Vaccine introduction, etc. Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oral Rotavirus Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
